SCHEMBL9904127

SCHEMBL9904127

Cn1c(=O)c2[nH]c(-c3cn(-c4ccccc4F)nn3)nc2n(C)c1=O

nearest known ligand 0.61

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
KDM4E B2RXH2 3/20 0.54
ADORA2B P29275 3/20 0.54
CYP1A2 P05177 1/20 0.54
ADORA3 P0DMS8 1/20 0.54
ADORA2A P29274 1/20 0.54
ADORA1 P30542 1/20 0.54
BLM P54132 1/20 0.54
NPSR1 Q6W5P4 1/20 0.54
HSD17B10 Q99714 1/20 0.54
ALDH1A1 P00352 1/20 0.50
HPGD P15428 1/20 0.50
TDP1 Q9NUW8 1/20 0.50
KDM4A O75164 1/20 0.47
GAA P10253 1/20 0.47
MAPT P10636 1/20 0.47
KMT2A Q03164 1/20 0.47
KDM4C Q9H3R0 1/20 0.47

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9904094 0.87 KDM4E (0.61) KDM4EADORA2BCYP1A2ADORA3ADORA2A
SCHEMBL9904184 0.87 ADORA2B (0.51) KDM4EADORA2BCYP1A2ADORA3ADORA2A
SCHEMBL9905475 0.85 KDM4E (0.52) KDM4EADORA2BCYP1A2ADORA3ADORA2A
SCHEMBL9904061 0.85 ADORA2B (0.51) KDM4EADORA2BCYP1A2ADORA3ADORA2A
SCHEMBL9904024 0.83 DCTPP1 (0.54) KDM4EADORA2BCYP1A2ADORA3ADORA2A
SCHEMBL9943740 0.81 ADORA2B (0.53) KDM4EADORA2BCYP1A2ADORA3ADORA2A
SCHEMBL9904138 0.78 ADORA2B (0.63) KDM4EADORA2BCYP1A2ADORA3ADORA2A
SCHEMBL9904131 0.78 ADORA2B (0.47) KDM4EADORA2BCYP1A2ADORA3ADORA2A
SCHEMBL9904114 0.77 MAPT (0.57) KDM4EADORA2BCYP1A2ADORA3ADORA2A
SCHEMBL9904130 0.77 ADORA2B (0.55) KDM4EADORA2BCYP1A2ADORA3ADORA2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2465859-A1 8-Triazolylxanthine derivatives, processes for their production and their use as adenosine receptor antagonists Life & Brain GmbH (DE) 2012-06-20 EP disclosed
WO-2012076974-A1 8-TRIAZOLYLXANTHINE DERIVATIVES, PROCESSES FOR THEIR PRODUCTION AND THEIR USE AS ADENOSINE RECEPTOR ANTAGONISTS LIFE & BRAIN GMBH (DE) 2012-06-14 WO disclosed
WO-2012076974-A1 8-TRIAZOLYLXANTHINE DERIVATIVES, PROCESSES FOR THEIR PRODUCTION AND THEIR USE AS ADENOSINE RECEPTOR ANTAGONISTS LIFE & BRAIN GMBH (DE) 2012-06-14 WO disclosed